Canada

India is poised to strengthen its access to critical minerals through strategic cooperation agreements with Germany and Canada, reflecting an urgent push to safeguard supply chains essential for clean energy, advanced manufacturing and digital infrastructure. The Union Cabinet is expected to approve the proposed partnerships, which aim to deepen collaboration in mineral exploration, processing technologies and long-term procurement frameworks.

Lupin Limited is set to commercialize a newly approved antidepressant in Canada, marking a strategic expansion of its North American portfolio. The move strengthens the company’s specialty and central nervous system, or CNS, product pipeline in a market characterized by rising demand for mental health treatments. By leveraging its established regulatory and distribution infrastructure, Lupin aims to enhance revenue diversification and reinforce its global generics and branded formulations presence.

India is intensifying efforts to secure critical mineral resources in Canada, aiming to bolster domestic supply chains for technology, energy, and defense sectors. With global demand for minerals such as lithium, cobalt, and rare earths surging, India is seeking strategic partnerships and investments to reduce import dependence and mitigate supply risks. Analysts highlight that Canada’s rich mineral reserves and stable regulatory environment make it a prime target for Indian investors and government-backed initiatives.

India and Canada are actively discussing a strategic cooperation framework aimed at deepening bilateral ties across trade, investment, technology, and sustainable development. The proposed agreement seeks to enhance collaboration in critical sectors, including clean energy, innovation, digital infrastructure, and defense. Both governments are engaging in high-level consultations to finalize the structure and scope of cooperation, reflecting mutual interest in strengthening economic and geopolitical partnerships.